Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J A Monn
Systemic Pre-Treatment With a Group II mGlu Agonist, LY379268, Reduces Hyperalgesiain Vivo
British Journal of Pharmacology
Pharmacology
Related publications
Altered Object Exploration but Not Temporal Order Memory Retrieval in an Object Recognition Test Following Treatment of Rats With the Group II Metabotropic Glutamate Receptor Agonist LY379268
Neuroscience Letters
Neuroscience
Pre-Treatment With Mesenchymal Stem Cells Reduces Ventilator-Induced Lung Injury
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
A Combined Opiate Agonist and Antagonist Treatment Reduces Prolactin Secreting Pituitary Tumor Growth
Journal of Cell Communication and Signaling
Biochemistry
Cell Biology
Molecular Biology
Multiple Family Group Treatment Reduces Distress for Caregivers of People With Schizophrenia
Evidence-Based Mental Health
Psychiatry
Mental Health
Treatment With TO901317, a Synthetic Liver X Receptor Agonist, Reduces Brain Damage and Attenuates Neuroinflammation in Experimental Intracerebral Hemorrhage
Journal of Neuroinflammation
Molecular Neuroscience
Neurology
Immunology
Cellular
Neuroscience
A Developed STING Agonist Has Systemic Antitumor Activity
Cancer Discovery
Oncology
Clinical Features and Treatment of Pre-Ulcerative Buruli Lesions: REPORT II OF THE UGANDA BURULI GROUP
BMJ
Class I and II Histone Deacetylase Inhibition by ITF2357 Reduces SLE Pathogenesis in Vivo
Clinical Immunology
Allergy
Immunology
Enhanced Sensitivity to Group II mGlu Receptor Activation at Corticostriatal Synapses in Mice Lacking the Familial Parkinsonism-Linked Genes PINK1 or Parkin
Experimental Neurology
Developmental Neuroscience
Neurology
